# HBsAg Loss Adding Pegylated Interferon in HBeAg-negative Patients

> **NCT02743182** · NA · COMPLETED · sponsor: **José Antonio Carrion** · enrollment: 119 (actual)

## Conditions studied

- Chronic Hepatitis B (HBeAg-negative)

## Interventions

- **DRUG:** Pegylated interferon alfa-2a

## Key facts

- **NCT ID:** NCT02743182
- **Lead sponsor:** José Antonio Carrion
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2018-10
- **Final completion:** 2018-11
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02743182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02743182, "HBsAg Loss Adding Pegylated Interferon in HBeAg-negative Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02743182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*